We are live on
!
Find out more
JF
Jump Financial Portfolio holdings
AUM
$7.5B
1-Year Est. Return
33.9%
This Fund
S&P 500
This Quarter
Est. Return
+5.93%
1 Year Est. Return
+33.9%
3 Year Est. Return
+69.87%
5 Year Est. Return
+55.07%
10 Year Est. Return
–
AUM
$2.71B
AUM Growth
+$256M
(+10%)
Cap. Flow
+$184M
Cap. Flow
% of AUM
6.78%
Top 10 Holdings %
Top 10 Hldgs %
6.67%
Holding
2,298
New
784
Increased
473
Reduced
488
Closed
552
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$19.5M |
| 2 |
Target
TGT
|
+$17.3M |
| 3 |
Royalty Pharma
RPRX
|
+$15.5M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$14.9M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$12.2M |
| 2 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$11M |
| 3 |
iShares Semiconductor ETF
SOXX
|
+$10.4M |
| 4 |
ProShares UltraPro Short QQQ
SQQQ
|
+$8.83M |
| 5 |
ProShares UltraPro S&P 500
UPRO
|
+$8.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.61% |
| 2 | Industrials | 13.75% |
| 3 | Healthcare | 12.7% |
| 4 | Consumer Discretionary | 12.54% |
| 5 | Financials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
PTC Therapeutics
PTCT
$5.82B
| $241K | 0.01% |
+5,916
| New | +$289K |
|
1427
S&P Global
SPGI
$122B
| $241K | 0.01% |
600
-1,787
| -75% | -$653K |
|
1428
MYR Group
MYRG
$5.32B
| $240K | 0.01% |
1,738
-19,674
| -92% | -$2.57M |
|
1429
Palantir
PLTR
$288B
| $240K | 0.01% |
15,683
-119,576
| -88% | -$1.36M |
|
1430
TPG
TPG
$6.86B
| $240K | 0.01% |
+8,200
| New | +$230K |
|
|
MDRX
1431
DELISTED
Veradigm Inc. Common Stock
MDRX
| $240K | 0.01% |
19,026
-3,297
| -15% | -$40K |
|
1432
Allient
ALNT
$1.47B
| $240K | 0.01% |
6,000
-1,400
| -19% | -$50.9K |
|
1433
Assured Guaranty
AGO
$3.69B
| $239K | 0.01% |
4,291
-470
| -10% | -$25K |
|
1434
Ingles Markets
IMKTA
$1.7B
| $239K | 0.01% |
+2,896
| New | +$249K |
|
1435
Mesa Laboratories
MLAB
$541M
| $238K | 0.01% |
+1,856
| New | +$283K |
|
1436
Kemper
KMPR
$1.66B
| $238K | 0.01% |
+4,934
| New | +$239K |
|
1437
Ralph Lauren
RL
$22.9B
| $237K | 0.01% |
1,922
-6,064
| -76% | -$700K |
|
1438
Dorchester Minerals
DMLP
$1.31B
| $237K | 0.01% |
+7,900
| New | +$232K |
|
1439
Liberty Global Class A
LBTYA
$3.55B
| $235K | 0.01% |
13,952
+2,857
| +26% | +$50.8K |
|
|
OPI
1440
DELISTED
Office Properties Income Trust
OPI
| $235K | 0.01% |
+30,547
| New | +$231K |
|
1441
Equinix
EQIX
$102B
| $235K | 0.01% |
+300
| New | +$220K |
|
1442
Aurinia Pharmaceuticals
AUPH
$1.86B
| $235K | 0.01% |
24,277
-9,077
| -27% | -$94.2K |
|
|
ALTR
1443
DELISTED
Altair Engineering Inc
ALTR
| $235K | 0.01% |
+3,097
| New | +$221K |
|
1444
Saia
SAIA
$9.21B
| $234K | 0.01% |
684
-267
| -28% | -$77.3K |
|
1445
Saic
SAIC
$4.86B
| $234K | 0.01% |
+2,081
| New | +$216K |
|
1446
Dominion Energy
D
$61.1B
| $234K | 0.01% |
+4,513
| New | +$245K |
|
1447
Power Integrations
POWI
$3.4B
| $233K | 0.01% |
+2,466
| New | +$206K |
|
|
CIR
1448
DELISTED
CIRCOR International, Inc
CIR
| $233K | 0.01% |
4,127
-12,810
| -76% | -$449K |
|
|
CPRX
1449
DELISTED
Catalyst Pharmaceutical
CPRX
| $232K | 0.01% |
17,269
-139,453
| -89% | -$2.01M |
|
1450
Peabody Energy
BTU
$2.59B
| $232K | 0.01% |
10,715
-195,728
| -95% | -$4.34M |
|
Similar funds
YAM
ASN
SP
AMH
BIM
CCM
GJL
DKCM
Jump Financial's Q2 2023 Portfolio in Review
As of Q2 2023, Jump Financial held 2,298 positions worth $2.71B, up 10% from $2.46B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Jump Financial deployed $184M of net new capital in Q2 2023, opening 784 new positions and adding to 473 existing holdings. Its largest new stake was Royalty Pharma: 456,285 shares worth $14M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $12.2M trimmed.
- Jump Financial's largest Q2 2023 buy was Royalty Pharma: 456,285 shares worth $14M.
- Jump Financial added most to State Street Utilities Select Sector SPDR ETF in Q2 2023, an estimated $19.5M increase.
- Jump Financial's biggest Q2 2023 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $12.2M.
- Jump Financial fully exited ProShares Short VIX Short-Term Futures ETF in Q2 2023, selling an estimated $11M.
- Jump Financial's ten largest holdings make up 6.7% of its $2.71B portfolio in Q2 2023.
- Jump Financial opened 784 new positions and closed 552 in Q2 2023.
- Jump Financial's portfolio value rose 10% quarter-over-quarter to $2.71B.
Based on Jump Financial's 13F filing for Q2 2023, filed 7 Aug 2023.